ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Determinants of Weight Loss and Regain in Men After Roux-En-Y Gastric Bypass: A Retrospective Analysis.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Men constitute a minority of bariatric surgery patients despite facing a high burden of obesity-related complications. Little is known about factors influencing long-term weight outcomes in male patients. We aimed to identify clinical and behavioral determinants of weight loss maintenance and weight regain in men after Roux-en-Y gastric bypass (RYGB). Methods: We retrospectively reviewed 100 men with obesity who underwent laparoscopic RYGB between 2013 and 2016. Inclusion was limited to those with ≥2 years of postoperative follow-up, yielding 43 patients for analysis. Clinical variables (age and comorbidities), behavioral factors (exercise and dumping syndrome - DS), and weight data were collected. Poisson regression identified factors associated with achieving normal body mass index (BMI) and significant weight regain. A linear regression model assessed predictors of percent excess weight loss (%EWL). Results: Paradoxically, men who achieved a normal BMI postoperatively had a higher risk of significant weight regain. Specifically, achieving a normal BMI was associated with a greater likelihood of ≥20% of total weight lost regained (adjusted prevalence ratio [PR] ~2.5, p<0.05). Longer follow-up duration was also associated with increased weight regain. On the other hand, the presence of DS was strongly associated with successful weight loss: men reporting dumping had a higher probability of attaining normal BMI (adjusted PR ~2.9, p<0.05). No other factors (age, baseline comorbidities, or exercise) showed significant associations with weight outcomes. Conclusion: RYGB is effective in men, leading to substantial weight loss and improvement in comorbidities. However, early success (achieving a normal BMI) did not guarantee long-term weight stability, as those patients were more prone to weight regain. These findings highlight the need for extended follow-up and targeted support in male bariatric patients to sustain weight loss outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.